Business Context and Reporting Period
This Form 8-K is a current report filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on March 2, 2017, regarding events occurring on March 1, 2017. The filing serves to announce the scheduled release of financial results for the fourth quarter and the full year ended December 31, 2016.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. It solely announces the timing of the upcoming financial report.
Material Changes
No material changes to financial performance or operations are detailed in this document. The filing is procedural, notifying investors of the date for the upcoming earnings release.
Guidance, Outlook, and Management Commentary
Upcoming Event: Trovagene, Inc. will report its financial results for the fourth quarter and year ended December 31, 2016, on Wednesday, March 15, 2017. A press release containing these details was issued on March 1, 2017, and is attached as Exhibit 99.1.
Important Facts for Investors to Verify
- Verify the company name: The filing is for Trovagene, Inc., not Cardiff Oncology, Inc.
- Confirm the earnings release date: March 15, 2017.
- Review the attached press release (Exhibit 99.1) for actual financial data, as this 8-K contains no numerical results.